Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,484 total articles
Cerebras's wafer-scale processors offer inference speeds that have captured headlines and a $20 billion customer commitment. The stock trades at a lofty market cap of ~$63.8B after a volatile IPO run. This trade targets a mid-term upside to $360 while protecting capital with a $255 stop, banking on adoption wins, proof-of-performance, and limited s…
Bit Digital is no longer just a miner. Between an active Ethereum accumulation plan funded by convertible notes, the October 2024 Enovum HPC datacenter acquisition, and an emerging colocation/WhiteFiber push, the company now mixes crypto treasury exposure with recurring-cloud revenue potential. The balance sheet shows pockets of strength (low lever…
Mosaic (MOS) is a beaten-down fertilizer producer trading near its 52-week low after a demand scare and a recent market rotation. A supply disruption earlier this year pushed fertilizer prices higher; with fundamentals still tight and valuation cheap on a book basis, a tactical long with a 45-trading-day horizon offers asymmetric upside. Entry at $…
IonQ's technical lead in trapped-ion fidelity, a pending SkyWater fabrication tie-up and accelerating revenue projections make the company a compelling mid-term long. Valuation is rich (market cap ~$18.4B; P/S ~98x), so this is a measured, tactical trade with a clear stop and target.
Fortinet is trading near its 52-week high as AI-driven security demand and cloud workload protection lift growth expectations. Fundamentals show robust free cash flow ($2.44B trailing) and high profitability metrics, while technicals point to bullish momentum and short interest that can fuel further moves. This trade idea sets an entry at $126.56 w…
Consolidated Water (CWCO) has seen its stock punished after delays to a Hawaiian desalination project and a manufacturing revenue collapse. The selloff looks overdone relative to a clean balance sheet ($126.3M cash), positive free cash flow ($27.9M), and identifiable catalysts to restore revenue. This is a long trade idea with a clearly defined ent…
IREN is transitioning from crypto-mining roots to a power-hungry AI infrastructure play backed by multi-billion dollar leases. The stock has run, sentiment is mixed, and the balance sheet and cash flow are still strained. This trade buys a measured pullback with clear risk controls: entry $50.00, stop $46.00, target $68.00 over a mid-term (45 tradi…
CenterPoint Energy is quietly reshaping its business toward electrification and large-scale infrastructure projects that serve data centers and AI customers. With partnerships that tie its grid operations to enterprise AI platforms, a $2.62B divestiture that reduces gas exposure, a 2.13% yield and a market cap near $27.3B, CNP looks like a practica…
Eli Lilly's pullback below $1,005 on 05/18/2026 looks like a healthy consolidation. Momentum indicators remain constructive and price sits near the 10-day/9-day moving averages. This trade idea uses a measured entry at $990, a tight stop under the 50-day structure, and a first target above the 52-week high to capture momentum re-acceleration while …
S&P Global (SPGI) is a diversified, high-margin data and ratings franchise trading well below prior highs after a pullback. Strong FCF, double-digit ROE, low leverage, and recurring revenue make this a quality compounder. This trade idea lays out an actionable swing trade with entry, stop, target, catalysts, and balanced risks.
Dutch Bros has the unit economics and customer frequency to behave like an energy-drink competitor inside a drive-thru coffee shell. Same-store sales momentum, a sizable loyalty base and aggressive unit growth underpin upside, while elevated valuation and momentum indicators argue for a disciplined entry with a defined stop. This trade idea lays ou…
Telix Pharmaceuticals is threading multiple clinical and commercial catalysts into 2026: an FDA PDUFA for its glioma imaging agent, expanded clinical data for kidney imaging, low-toxicity dosimetry for its next-gen PSMA therapeutic, and a partnership with Regeneron that brings $40M up front plus sizable upside. With market cap at roughly $3.49B and…
McDonald's (MCD) combines durable franchise economics with optional upside from digital and AI-driven operating improvements. This trade idea looks for modest capital appreciation over a 180 trading day horizon while defending against margin pressure with a tight stop.
Parex Resources looks positioned to meaningfully re-rate as new development wells and infrastructure investments push production materially higher in the next 12 months. We initiate a strong buy with an entry at $8.50, a stop at $7.00 and a primary target of $12.00 over a 180 trading day horizon.
Monster delivered another solid quarter and continues to generate robust free cash flow and high returns on equity. That strength is already priced in: MNST trades near its 52-week high at ~ $88.55, with a P/E ~42 and EV/EBITDA ~30.8. Given stretched multiples, elevated RSI, and limited upside versus downside, we present a swing trade short with de…
Zscaler is trading off its 52-week highs but shows clear momentum and fundamental support as enterprises prioritize AI-safe cloud security. Strong free cash flow, accelerating technical momentum and a rising short-interest backdrop create a favorable asymmetric trade into earnings. This idea gives an entry at $177.21, a stop at $150.00 and a long-t…
Humana (HUM) slid after weak fiscal-2026 EPS guidance and membership softness, but the CMS 2027 Medicare Advantage capitation boost, solid cash flow, and an attractive enterprise multiple argue for a tactical buy on weakness. I upgrade to Buy with a clear entry, stop, and target for a swing/position trade over the next 45 trading days.
Starz has ripped higher from its February low but fundamentals and technicals still support further gains. The company trades below book, shows improving adjusted OIBDA after the spinoff, and carries elevated short interest that could amplify moves. We lay out a mid-term (45 trading days) long trade with an entry at $22.00, stop at $19.50 and a $28…
Alibaba is repositioning from a mature e-commerce cash machine into an AI infrastructure and cloud growth compounder. With cloud intelligence revenue growing 38% and adjusted EBITA up 57% recently, a $320B market cap and a P/E near 20, the stock looks set to re-rate if AI monetization continues. This trade proposes a controlled long with a $132.50 …
IREN has high-profile AI contracts that justify investor interest, but a costly transition to AI, negative free cash flow, a $2B convertible offering and very rich valuation create asymmetric downside in the near-to-mid term. We recommend a mid-term short with a clear entry, stop and target tied to operational and capital-marketing risk.
Service Corporation International (SCI) is a defensive, cash-generative play on North America's aging demographics and growing preference for cemetery-based revenue streams. At $78.62 today, SCI trades at roughly $10.9B market cap with a PE near 20 and EV/EBITDA ~11.9. For investors seeking income and low volatility exposure to deathcare services, …
Regeneron plunged after a Phase 3 fianlimab combination narrowly missed statistical significance for PFS (p=0.0627). The drop creates a tactical buying opportunity. The company still generates strong free cash flow, has low leverage, and multiple near-term catalysts. This trade idea grades REGN higher and lays out entry, stop, and target levels acr…
Mitsubishi UFJ Financial Group posted an earnings beat and is showing signs of return-on-equity expansion amid a higher-yield environment and a weakening yen. Valuation is reasonable (P/E ~13.3, P/B ~1.52) and technical momentum is constructive. We lay out a mid-term swing trade to capture further upside while keeping defined risk controls.
Robinhood has been punished for a crypto revenue slump and a near-term miss. That pain is priced in today around $76, but recent transaction gains in prediction markets, a 27.4 million funded customer base, and solid free cash flow create a favorable asymmetric trade. We upgrade to a tactical long with a mid-term plan to capture re-rating as the co…
Pitney Bowes (PBI) looks attractively positioned after a year of operating and cash-flow improvement. At ~$16.45 the stock trades at a modest multiple to earnings and strong free cash flow, yields a low-single-digit dividend, and has catalysts that could re-rate the multiple. This trade plan targets $20 over a 180-trading-day horizon with a $14 sto…
